Form EFFECT FibroBiologics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics (FBLG) files for 12.53M share offering by selling stockholders
- SECUR3D Begins Trading on The Canadian Securities Exchange and Provides Corporate Update
- Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share